SBS says it is advising investors in ARS Pharmaceuticals securities lawsuit
Schall, Brown & Schwartz LLP said ARS Pharmaceuticals investors may contact the firm about a proposed securities-fraud class action tied to neffy coverage timing.
Legal
SBS says Pentair investors may seek lead plaintiff roles in securities suit
Schall, Brown & Schwartz LLP says investors in Pentair plc may seek lead plaintiff roles in a securities class action tied to alleged disclosures about the company’s Pool channel destocking.
DJS Law Group points investors to Bloom Energy class action over scandium claims
The law firm’s Sept. 8 press release says the suit covers Bloom Energy shares bought from Feb. 27, 2025, through July 8, 2026.
DJS Law Group reminds investors about PROCEPT BioRobotics securities class action
A PR Newswire release says DJS Law Group is reminding investors about a securities class action against PROCEPT BioRobotics over alleged misleading statements and aggressive discounting.
Wix investors told they may seek lead plaintiff status in securities suit
Schall, Brown & Schwartz LLP said Wix investors may seek lead plaintiff status in a securities lawsuit that accuses the company of misleading statements about AI products and costs.
Schall, Brown & Schwartz files Beta Bionics securities class action over iLet claims
The law firm says investors who bought Beta Bionics stock during the alleged class period may seek lead-plaintiff status by Nov. 3, 2026.
DJS Law Group says investors may contact firm in GPGI securities case
DJS Law Group issued a reminder about a securities class action against GPGI, Inc., formerly CompoSecure, Inc., over allegations tied to the Husky Technologies acquisition.